ClinicalTrials.Veeva

Menu

Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

COVID-19

Treatments

Behavioral: Testing Navigation Intervention (TNI).
Behavioral: Control
Behavioral: Facilitated Self-Sampling Intervention (FSSI)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05606016
3UL1TR003167-03S3 (U.S. NIH Grant/Contract)
HSC-SPH-20-1372 Embedded Study

Details and patient eligibility

About

Antigen self-testing kits are more available at this stage in the pandemic, but among vulnerable populations, use is still low and instructions for antigen testing are not typically designed for low health literacy populations. Studies are needed to explore access and use of antigen tests among vulnerable populations and examine if low-health-literacy-designed interventions improve COVID-19 testing decisions and behaviors. This study will focus on understanding factors associated with rapid COVID-19 testing, specifically. The primary objectives of the embedded study are to 1) Determine the effectiveness of community-level intervention using door-to-door recruitment and education in increasing COVID-19 testing and 2) Compare the effectiveness of the CHW- Facilitated Self-Sampling Intervention (FSSI) vs. CHW Testing Navigation Intervention (TNI).

Full description

The pandemic landscape and people's experiences with testing, infection, and vaccination have changed dramatically over the past two years. Vaccines have become available, testing access in local communities has waxed and waned, and attitudes toward COVID-19 severity and susceptibility have shifted. Navigating the testing-decision landscape is confusing to the public (test availability for free versus charged or requiring insurance; testing and vaccination locations change; PCR versus antigen testing; home tests versus clinically delivered; symptom-based testing, exposure-driven testing, serial testing, resources to trust or not trust, etc.).

This study, referred to as the embedded study, builds off a broader population-based group randomized controlled trial (RCT) to evaluate the effects of a Facilitated Self-Sampling Intervention and Testing Navigation Intervention on testing behaviors. The embedded study will randomly select and assign priority block groups from the RCT to one of three arms - FSSI (n=16), TNI (n=16), or Control (n= 32). The allocation will be at a 2:1:1 rate across the three regions Houston/Harris County, South Texas, and Northeast Texas respectively. Community Health Workers will systematically sample and recruit 20 individuals from each PBG using a random start procedure. Study participants in the intervention arms will be enrolled, complete a baseline survey, receive a brief educational intervention, and complete a follow-up survey. Participants in the control arm will complete a baseline and follow-up survey.

Enrollment

1,232 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 18 years or older

Exclusion criteria

  • Having been diagnosed with COVID-19 in the past 30 days based on a positive test (antigen or PCR) or a clinical diagnosis
  • Having tested for COVID-19 with PCR or antigen test within the past 30 days

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,232 participants in 3 patient groups

Facilitated Self-Sampling Intervention (FSSI)
Experimental group
Description:
Participants in the FSSI arm will receive education on COVID-19 testing and be provided with rapid antigen tests. Participants will also receive pre and post surveys.
Treatment:
Behavioral: Facilitated Self-Sampling Intervention (FSSI)
Testing Navigation Intervention (TNI).
Experimental group
Description:
Participants in the TNI arm will receive COVID-19 testing education and be navigated to PCR testing sites. Participants will also receive pre and post surveys.
Treatment:
Behavioral: Testing Navigation Intervention (TNI).
Control
Active Comparator group
Description:
Participants in the Control Group arm will receive a CDC-designed COVID-19 testing brochures, and pre and post surveys only.
Treatment:
Behavioral: Control

Trial contacts and locations

3

Loading...

Central trial contact

Maria E Fernandez, PhD; Ibette Cavazos

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems